tor- by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice. Am J Physiol Gastrointest Liver Physiol 302: G548–G557, 2012. First published December 15, 2012; doi:10.1152/ajpgi.00342.2011.—The development of alcohol-induced fatty liver is associated with a reduction of white adipose tissue (WAT). Peroxisome proliferator-activated receptor (PPAR)- promi-nently distributes in the WAT and plays a crucial role in maintaining adiposity. The present study investigated the effects of PPAR- activation by rosiglitazone on lipid homeostasis at the adipose tissue-liver axis. Adult C57BL/6 male mice were pair fed liquid diet containing ethanol or isocaloric maltose dextrin for 8 wk with or without rosiglitazon...
Background and aims: Chronic ethanol exposure results in inflammation in adipose tissue; this respon...
Genetically diabetic Akita mice, kept on a high-fat and high-cholesterol diet, and treated with the ...
STAT6 interacts with PPARγ to elicit macrophage polarization towards an anti-inflammatory, insulin-s...
The development of alcoholic fatty liver is associated with reduced adipocyte-derived adiponectin le...
Alcohol consumption is a major cause of liver disease. It also associates with increased cardiovascu...
Obesity is associated with chronic low-grade inflammation that drives the development of metabolic d...
Thiazolidinediones (TZD) are peroxisome proliferator-activated receptor γ (PPARγ) agonists that may ...
The mechanisms underlying alcoholic liver disease are not completely understood, but lipid accumulat...
Alcohol consumption induces liver steatosis; therefore, this study investigated the possible role of...
Chronic alcoholic liver disease is associated with hepatic insulin resistance, inflammation, oxidati...
Rosiglitazone is an agonist of peroxisome proliferator-activated receptor- (PPAR-) γ that is princip...
2004; 10.1152/ajpgi.00056.2004.—Alcohol has long been thought to cause fatty liver by way of altered...
Peroxisome proliferator-activated receptors (PPARs) participate in the molecular mechanism of pathol...
Peroxisome proliferator-activated receptors (PPAR) play an important role in the regulation of lipid...
Treatment with rosiglitazone, a potent peroxisome proliferator–activated receptor (PPAR) γ agonist, ...
Background and aims: Chronic ethanol exposure results in inflammation in adipose tissue; this respon...
Genetically diabetic Akita mice, kept on a high-fat and high-cholesterol diet, and treated with the ...
STAT6 interacts with PPARγ to elicit macrophage polarization towards an anti-inflammatory, insulin-s...
The development of alcoholic fatty liver is associated with reduced adipocyte-derived adiponectin le...
Alcohol consumption is a major cause of liver disease. It also associates with increased cardiovascu...
Obesity is associated with chronic low-grade inflammation that drives the development of metabolic d...
Thiazolidinediones (TZD) are peroxisome proliferator-activated receptor γ (PPARγ) agonists that may ...
The mechanisms underlying alcoholic liver disease are not completely understood, but lipid accumulat...
Alcohol consumption induces liver steatosis; therefore, this study investigated the possible role of...
Chronic alcoholic liver disease is associated with hepatic insulin resistance, inflammation, oxidati...
Rosiglitazone is an agonist of peroxisome proliferator-activated receptor- (PPAR-) γ that is princip...
2004; 10.1152/ajpgi.00056.2004.—Alcohol has long been thought to cause fatty liver by way of altered...
Peroxisome proliferator-activated receptors (PPARs) participate in the molecular mechanism of pathol...
Peroxisome proliferator-activated receptors (PPAR) play an important role in the regulation of lipid...
Treatment with rosiglitazone, a potent peroxisome proliferator–activated receptor (PPAR) γ agonist, ...
Background and aims: Chronic ethanol exposure results in inflammation in adipose tissue; this respon...
Genetically diabetic Akita mice, kept on a high-fat and high-cholesterol diet, and treated with the ...
STAT6 interacts with PPARγ to elicit macrophage polarization towards an anti-inflammatory, insulin-s...